Recall of Blood Pressure Medication Bottles
Over 580,000 bottles of blood pressure medication have been recalled by the U.S. Food and Drug Administration (FDA), according to a new Enforcement Report.
The recall affects certain lots of the antihypertensive drug prazosin hydrochloride, manufactured by Teva Pharmaceuticals, which tested positive for elevated levels of a potential carcinogenic impurity.
- 1 milligram (mg) capsules
- 2 mg capsules
- 5 mg capsules
The affected bottles can be identified by lot number and expiration date, as outlined in the FDA report.
It’s essential to consult your physician before stopping a medication, even if you’re concerned that your bottles are affected.
For more information, refer to the FDA report for recall specifics.
Author summary: Medication recall due to carcinogenic impurity.
More News
- Brendan Keaney on the dance sector's future strategy
- 'BHV has muddled its own narrative by associating with Shein'
- How Blue Jays' Vladimir Guerrero Jr. already joined Barry Bonds in World Series history
- Night dives reveal hidden alliances between young fish and larval anemones
- Stephen A. Smith Questions Why Chris Grier Got Fired Before Mike McDaniel After Dolphins' Embarrassing Loss
- Why Ryan Rollins loved Draymond Green coming for him after Stephen Curry incident
- No Giannis, No Problem — Bucks Take Down Warriors as Antetokounmpo Steals the Show in Minion Costume
- Maria Becerra’s Sultry ‘JOJO’ & More Best New Music Latin
- Memoori: Hybrid Architectures, Cybersecurity Drive Change in Video Surveillance
- Gradam RTÉ Raidió na Gaeltachta 2025 to be presented to Mayo native - news - Western People